ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc. is a clinical-stage biotechnology company focused on discovering and developing antibody therapeutics for neurodegenerative diseases. They specialize in targeting toxic misfolded proteins, which are thought to play a key role in the development and progression of conditions like Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). ProMIS leverages its proprietary target discovery engine, utilizing computational algorithms to identify and predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of these misfolded proteins.

The company's unique approach focuses on developing highly selective antibodies that target only the toxic forms of proteins, leaving the normal, essential forms unaffected. ProMIS Neurosciences is actively pursuing a pipeline of antibody therapies and vaccines targeting various misfolded proteins implicated in neurodegenerative diseases. Their commitment to research and development has resulted in a robust patent portfolio and a significant presence in the field of neurodegenerative medicine.

ProMIS Neurosciences is a clinical-stage biotechnology company committed to developing antibody therapies that target the toxic misfolded proteins implicated in neurodegenerative diseases like Alzheimer's, ALS, and MSA. Their unique approach leverages computational modeling to accurately predict and identify these misfolded proteins, allowing for the development of highly selective antibodies that specifically target the toxic forms without affecting the essential functions of the normal proteins. ProMIS strives to bring these therapies to patients, offering hope for a future with effective treatments for these devastating diseases.

ProMIS Neurosciences cultivates a collaborative and innovative culture driven by a shared passion for developing groundbreaking treatments for neurodegenerative diseases. The company fosters a multidisciplinary environment that values expertise and encourages open communication, teamwork, and a dedication to scientific excellence.

ProMIS Neurosciences, Inc. is committed to fostering a diverse, equitable, and inclusive workplace that values the unique contributions of all employees. They strive to create a culture where everyone feels respected, valued, and empowered to reach their full potential. ProMIS believes that diversity in thought, background, and experience leads to innovation, creativity, and a stronger company overall. They actively recruit and retain a diverse workforce, promote inclusivity through employee resource groups, and provide opportunities for professional development and advancement to all employees.